The fund is an actively managed exchange-traded fund (“ETF”) that seeks to attain its investment objective by investing primarily in equity securities of foreign companies. The fund typically invests in foreign companies with market capitalizations (market value of publicly traded equity securities) greater than $5 billion at the time of purchase. Show more
Location: | Industry: | Sector:
Market Cap
0.00
52 Wk Range
$28.93 - $36.44
Previous Close
$35.98
Open
$35.98
Volume
18,563
Day Range
$35.86 - $35.98
Enterprise Value
0.00
Cash
0.00
Avg Qtr Burn
N/A
Insider Ownership
0.00%
Institutional Own.
0.00%
Qtr Updated
06/30/24
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
BI-1607 + KEYTRUDA & Ipilimumab Details Cancer, Melanoma | Phase 2 Initiation | |
BI-1910 + KEYTRUDA Details Solid tumor/s, Cancer | Phase 2a Data readout | |
Phase 2a Data readout | ||
Phase 2a Data readout | ||
BT-001 + KEYTRUDA Details Cancer, Solid tumor/s | Phase 1/2 Update | |
BI-1607 Details Solid tumor/s, Cancer | Phase 1 Data readout | |
BI-1206 + KEYTRUDA Details Solid tumors | Phase 1 Data readout |